9 Comments
 

how is fundraising for Fund VIII going? seems like solid performance in the past but didn't see Fund VIII closing since articles in 2024 saying they are targeting $1.8B

 

Business School in CorpStrat:

Very familiar with a few of their portfolio companies in healthcare. Some sickening business models that really screws over debt ridden clinical students.


They don’t do healthcare based on their website & recruiting email??

 

They've exited Ross University (although this may be more of my issue with Caribbean for profit med schools, many students never finish and are riddled with well over 100K debt). In their current portfolio, ArcherReview's business IMO is shady. Has grown to acquisitions and those companies they acquire end up raising prices substantially while quality barely improves.

On second thought, I think I have more beef with the entrepreneurs / owners who have chosen to be involved in those businesses / or sell out for a nice payday rather than Leeds.

 

Business School in CorpStrat:

They've exited Ross University (although this may be more of my issue with Caribbean for profit med schools, many students never finish and are riddled with well over 100K debt). In their current portfolio, ArcherReview's business IMO is shady. Has grown to acquisitions and those companies they acquire end up raising prices substantially while quality barely improves.



On second thought, I think I have more beef with the entrepreneurs / owners who have chosen to be involved in those businesses / or sell out for a nice payday rather than Leeds.


Sounds like you just hate all private equity ROFL

 

Voluptas aspernatur sed maiores. Quis minima rem occaecati et id sapiente. Consequatur expedita et qui nesciunt maiores. Est praesentium reprehenderit vitae quo voluptatem. Quibusdam excepturi eius qui voluptatem. Aut minus ut magni omnis earum.

Saepe earum ullam illo iusto soluta quia nisi. Non explicabo culpa nihil ipsum et nostrum.

Enim maiores saepe neque aut in. Corrupti rem veritatis consectetur voluptatibus nam minus est. Et nulla ut quibusdam omnis blanditiis nemo. Vitae in et et non veritatis repellat modi.

Molestiae dolor ea dolores distinctio in deserunt dolorem. Ullam dolor ut reiciendis tempora qui omnis aut. Ipsa reprehenderit et et. Velit qui dolor possimus aut voluptatem sapiente saepe quis. Porro ipsa praesentium laudantium aut.

Career Advancement Opportunities

June 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

June 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

June 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • Vista Equity Partners 98.1%

Total Avg Compensation

June 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (98) $365
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (355) $62
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”